Valeant is being sued under racketeering law over drug price hikes By: MarketWatch August 29, 2016 at 16:35 PM EDT Class action lawsuit claims that ‘exorbitant’ price increases exacerbated injuries. Read More >> Related Stocks: Standard & Poors 500 Valeant Pharmaceuticals International, Inc.